Heron Therapeutics
HRTX
#9737
Rank
C$0.12 B
Marketcap
C$0.66
Share price
-2.01%
Change (1 day)
-74.54%
Change (1 year)

Revenue for Heron Therapeutics (HRTX)

Revenue in 2026 (TTM): C$0.20 Billion

According to Heron Therapeutics's latest financial reports the company's current revenue (TTM ) is C$0.21 Billion. In 2025 the company made a revenue of C$0.21 Billion an increase over the revenue in the year 2024 that were of C$0.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Heron Therapeutics from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) C$0.20 B-2.11%
2025 C$0.21 B2.46%
2024 C$0.20 B22.87%
2023 C$0.16 B15.33%
2022 C$0.14 B32.77%
2021 C$0.11 B-2.63%
2020 C$0.11 B-40.72%
2019 C$0.19 B80.64%
2018 C$0.10 B172.83%
2017 C$38.68 M2150.53%
2016 C$1.71 M
2015 N/A
2014 N/A
2013 N/A
2012 N/A-100%
2011 C$0.65 M-49.47%
2010 C$1.3 M-1.99%
2009 C$1.32 M194.93%
2008 C$0.44 M
2005 C$6.27 M-3.3%
2004 C$6.49 M3.19%
2003 C$6.29 M-27.98%
2002 C$8.73 M24.97%
2001 C$6.98 M38.6%
2000 C$5.04 M-83.48%
1999 C$30.52 M0.26%
1998 C$30.44 M17.07%
1997 C$26 M0.99%
1996 C$25.75 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
SurModics
SRDX
C$0.17 B-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
C$1.03 B 387.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
C$0.38 B 82.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
C$2.19 B 936.61%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
C$78.29 M-63.09%๐Ÿ‡บ๐Ÿ‡ธ USA